Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marwa Sabe, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Locke AH, Gurin MI, Sabe M, Hauser TH, Zimetbaum P. Arrhythmia in Cardiac Sarcoidosis. Cardiol Rev. 2021 May-Jun 01; 29(3):131-142. PMID: 32941259.
    Citations:    Fields:    
  2. Jiang GY, Cai Q, Grandin EW, Sabe MA. Fulminant cardiac sarcoidosis resembling giant cell myocarditis: a case report. Eur Heart J Case Rep. 2021 Mar; 5(3):ytab042. PMID: 33733047.
  3. Eche IM, Owen KL, Eche IJ, Patel P, Sabe M. Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failure. J Cardiovasc Pharmacol Ther. 2021 Jul; 26(4):365-370. PMID: 33563034.
    Citations:    Fields:    
  4. Hammond MM, Shen C, Li S, Kazi DS, Sabe MA, Garan AR, Markson LJ, Manning WJ, Klein AL, Nagueh SF, Strom JB. Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience. PLoS One. 2020; 15(12):e0244379. PMID: 33351853.
    Citations:    Fields:    Translation:Humans
  5. Rao P, Katz D, Hieda M, Sabe M. How to Manage Temporary Mechanical Circulatory Support Devices in the Critical Care Setting: Translating Physiology to the Bedside. Heart Fail Clin. 2020 Jul; 16(3):283-293. PMID: 32503752.
    Citations:    Fields:    Translation:Humans
  6. Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020 02 11; 141(6):e69-e92. PMID: 31902242.
    Citations: 54     Fields:    Translation:Humans
  7. Gulati G, Kiernan M, Sabe MA. Massive retroperitoneal hemorrhage after external shock wave lithotripsy in a patient with a left ventricular assist device. Urol Case Rep. 2020 Jan; 28:101033. PMID: 31641612.
  8. Miller C, Arkun K, DeNofrio D, Sabe M. Antibody-mediated rejection 16 years post-cardiac transplantation: a case report of an uncommon late presentation in a middle-aged woman. Eur Heart J Case Rep. 2019 Sep 01; 3(3). PMID: 31365068.
  9. Sabe MA, Sabe SA, Kusunose K, Flamm SD, Griffin BP, Kwon DH. Predictors and Prognostic Significance of Right Ventricular Ejection Fraction in Patients With Ischemic Cardiomyopathy. Circulation. 2016 Aug 30; 134(9):656-65. PMID: 27507405.
    Citations: 14     Fields:    Translation:Humans
  10. Sabe MA, Claggett B, Burdmann EA, Desai AS, Ivanovich P, Kewalramani R, Lewis EF, McMurray JJ, Olson KA, Parfrey P, Solomon SD, Pfeffer MA. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J Am Heart Assoc. 2016 04 23; 5(4). PMID: 27108247.
    Citations: 10     Fields:    Translation:Humans
  11. Sabe MA, Jacob MS, Taylor DO. In Reply: The PARADIGM-HF trial. Cleve Clin J Med. 2016 Mar; 83(3):167-8. PMID: 26974983.
    Citations: 1     Fields:    
  12. Sabe MA, Jacob MS, Taylor DO. A new class of drugs for systolic heart failure: The PARADIGM-HF study. Cleve Clin J Med. 2015 Oct; 82(10):693-701. PMID: 26469827.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  13. Sabe MA, Shrestha NK, Gordon S, Menon V. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis. Eur Heart J Acute Cardiovasc Care. 2014 Sep; 3(3):275-80. PMID: 24523355.
    Citations: 13     Fields:    Translation:HumansCells
  14. Sabe MA, Shrestha NK, Menon V. Contemporary drug treatment of infective endocarditis. Am J Cardiovasc Drugs. 2013 Aug; 13(4):251-8. PMID: 23640269.
    Citations: 2     Fields:    Translation:Humans
  15. Finney MR, Fanning LR, Joseph ME, Goldberg JL, Greco NJ, Bhakta S, Winter DG, Forster M, Scheid PE, Sabe M, Pompili VJ, Laughlin MJ. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Cytotherapy. 2010; 12(1):67-78. PMID: 19878081.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sabe's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (92)
Co-Authors (17)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.